Clonidine Transdermal Patch and Insulin Icodec-Abae: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Clonidine Transdermal Patch
Insulin Icodec-Abae
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
An increased risk of hypoglycemia, which may sometimes be followed by hyperglycemia, an increased risk of blunted recognition of hypoglycemia signs and symptoms and reduced efficacy of insulin icodec-abae
Interaction Deep Dive
Concomitant use of insulin icodec-abae and cloNIDine (sympathomimetic agent) may increase or reduce the blood glucose lowering effect of insulin icodec-abae. Concomitant use may also blunt signs and symptoms of hypoglycemia. Dose adjustment and increased frequency of glucose monitoring may be required with coadministration1.
Why it happens (mechanism)
Altered blood glucose lowering effects of insulin icodec-abae; reduced blood glucose lowering effects of insulin icodec-abae
Common questions
Can I take Clonidine Transdermal Patch and Insulin Icodec-Abae together?
An increased risk of hypoglycemia, which may sometimes be followed by hyperglycemia, an increased risk of blunted recognition of hypoglycemia signs and symptoms and reduced efficacy of insulin icodec-abae Always confirm with your pharmacist or prescriber before making any change.
How serious is the Clonidine Transdermal Patch and Insulin Icodec-Abae interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Clonidine Transdermal Patch or Insulin Icodec-Abae need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: AWIQLI subcutaneous injection, insulin icodec-abae subcutaneous injection. Novo Nordisk Inc. (Per FDA), Plainsboro, NJ, 2026. DailyMed
Keep reading about Clonidine Transdermal Patch
Keep reading about Insulin Icodec-Abae
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist